Search
for
Sort by
Research 331–360 of 343
- Ganoderma lucidum extract attenuates corticotropin-releasing hormone induced cellular senescence in human hair follicle cells
- Polycystic ovary syndrome
- Fibroblasts in Diabetic Foot Ulcers
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- 573 Discovery of JW0061, a novel GFRA1 agonist, as a hair regeneration stimulant via WNT signaling activation in dermal papilla cells
- [RETRACTED] FoliPrime Reviews: Will Foli Prime Hair Support Formula Work for You? v1
- [RETRACTED] FoliPrime Serum Reviews – Is Foli Prime Legit or Cheap Supplement Brand? v1
- [RETRACTED] FoliPrime Reviews: Ingredients, Side Effects, Pros & Cons Here! v1
- [RETRACTED] Folicrex: Know This First Before Buying Hair Regrowth Pills? v1
- [RETRACTED] Folicrex: Know This First Before Buying Hair Regrowth Pills? v1
- Restolin Hair Supplement: Here are Some Effective Remedies for Hair Fall Control! v1
- [RETRACTED] Restolin Hair Supplement: Here are Some Effective Remedies for Hair Fall Control! v1
- [RETRACTED] Restolin Reviews Amazon: UK, USA, Australia, South Africa, Canada, NZ (Ingredients Updates) v1
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review
- GLP‐1 agonists and hair loss: a call for further investigation
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia
- Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- Are Pediatric GLP ‐1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age‐Specific Patterns and Their Implications for Dermatologists
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review
- Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Clinical and mechanistic effects of GLP-1 receptor agonists in hidradenitis suppurativa and comorbidities